Emiliano Calvo on cutting-edge systemic cancer therapies
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Emiliano Calvo on cutting-edge systemic cancer therapies
-
Narrated by:
-
By:
In this episode, Deputy Editor Ivana Nedic is joined by Dr Emiliano Calvo to discuss the rapidly evolving landscape of systemic cancer therapies. Ahead of the upcoming Series in The Lancet Regional Health – Europe, they explore its four key pillars: next-generation antibody-based therapies, antibody-drug conjugates, oncolytic viruses and cancer vaccines, and emerging cell therapies for solid tumours. The conversation examines the scientific advances driving these approaches, the challenges of toxicity management and equitable access across Europe, and how these innovative modalities may be sequenced and combined in the years ahead to reshape cancer care.
No reviews yet